Journal article 1056 views 635 downloads
Clinical relevance of pharmacokinetic and pharmacodynamic profiles of insulin degludec (100, 200 U/mL) and insulin glargine (100, 300 U/mL) – a review of evidence and clinical interpretation
Diabetes & Metabolism
Swansea University Author: David Owens
-
PDF | Accepted Manuscript
Released under the terms of a Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND).
Download (932.57KB)
DOI (Published version): 10.1016/j.diabet.2018.11.004
Abstract
Clinical relevance of pharmacokinetic and pharmacodynamic profiles of insulin degludec (100, 200 U/mL) and insulin glargine (100, 300 U/mL) – a review of evidence and clinical interpretation
Published in: | Diabetes & Metabolism |
---|---|
ISSN: | 12623636 |
Published: |
2018
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa46120 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
first_indexed |
2018-11-27T20:19:27Z |
---|---|
last_indexed |
2019-04-15T09:24:31Z |
id |
cronfa46120 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2019-04-11T11:43:05.4206116</datestamp><bib-version>v2</bib-version><id>46120</id><entry>2018-11-27</entry><title>Clinical relevance of pharmacokinetic and pharmacodynamic profiles of insulin degludec (100, 200 U/mL) and insulin glargine (100, 300 U/mL) – a review of evidence and clinical interpretation</title><swanseaauthors><author><sid>2fd4b7c3f82c6d3bd546eff61ff944e9</sid><ORCID>0000-0003-1002-1238</ORCID><firstname>David</firstname><surname>Owens</surname><name>David Owens</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2018-11-27</date><deptcode>BMS</deptcode><abstract/><type>Journal Article</type><journal>Diabetes & Metabolism</journal><publisher/><issnPrint>12623636</issnPrint><keywords/><publishedDay>31</publishedDay><publishedMonth>12</publishedMonth><publishedYear>2018</publishedYear><publishedDate>2018-12-31</publishedDate><doi>10.1016/j.diabet.2018.11.004</doi><url/><notes/><college>COLLEGE NANME</college><department>Biomedical Sciences</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>BMS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2019-04-11T11:43:05.4206116</lastEdited><Created>2018-11-27T14:52:00.4600487</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>D.R.</firstname><surname>Owens</surname><order>1</order></author><author><firstname>T.</firstname><surname>S Bailey</surname><order>2</order></author><author><firstname>C.G.</firstname><surname>Fanelli</surname><order>3</order></author><author><firstname>J.-F.</firstname><surname>Yale</surname><order>4</order></author><author><firstname>G.B.</firstname><surname>Bolli</surname><order>5</order></author><author><firstname>David</firstname><surname>Owens</surname><orcid>0000-0003-1002-1238</orcid><order>6</order></author></authors><documents><document><filename>0046120-27112018145400.pdf</filename><originalFilename>Owens2018.pdf</originalFilename><uploaded>2018-11-27T14:54:00.3100000</uploaded><type>Output</type><contentLength>944937</contentLength><contentType>application/pdf</contentType><version>Accepted Manuscript</version><cronfaStatus>true</cronfaStatus><embargoDate>2019-11-26T00:00:00.0000000</embargoDate><documentNotes>Released under the terms of a Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND).</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language></document></documents><OutputDurs/></rfc1807> |
spelling |
2019-04-11T11:43:05.4206116 v2 46120 2018-11-27 Clinical relevance of pharmacokinetic and pharmacodynamic profiles of insulin degludec (100, 200 U/mL) and insulin glargine (100, 300 U/mL) – a review of evidence and clinical interpretation 2fd4b7c3f82c6d3bd546eff61ff944e9 0000-0003-1002-1238 David Owens David Owens true false 2018-11-27 BMS Journal Article Diabetes & Metabolism 12623636 31 12 2018 2018-12-31 10.1016/j.diabet.2018.11.004 COLLEGE NANME Biomedical Sciences COLLEGE CODE BMS Swansea University 2019-04-11T11:43:05.4206116 2018-11-27T14:52:00.4600487 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine D.R. Owens 1 T. S Bailey 2 C.G. Fanelli 3 J.-F. Yale 4 G.B. Bolli 5 David Owens 0000-0003-1002-1238 6 0046120-27112018145400.pdf Owens2018.pdf 2018-11-27T14:54:00.3100000 Output 944937 application/pdf Accepted Manuscript true 2019-11-26T00:00:00.0000000 Released under the terms of a Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND). true eng |
title |
Clinical relevance of pharmacokinetic and pharmacodynamic profiles of insulin degludec (100, 200 U/mL) and insulin glargine (100, 300 U/mL) – a review of evidence and clinical interpretation |
spellingShingle |
Clinical relevance of pharmacokinetic and pharmacodynamic profiles of insulin degludec (100, 200 U/mL) and insulin glargine (100, 300 U/mL) – a review of evidence and clinical interpretation David Owens |
title_short |
Clinical relevance of pharmacokinetic and pharmacodynamic profiles of insulin degludec (100, 200 U/mL) and insulin glargine (100, 300 U/mL) – a review of evidence and clinical interpretation |
title_full |
Clinical relevance of pharmacokinetic and pharmacodynamic profiles of insulin degludec (100, 200 U/mL) and insulin glargine (100, 300 U/mL) – a review of evidence and clinical interpretation |
title_fullStr |
Clinical relevance of pharmacokinetic and pharmacodynamic profiles of insulin degludec (100, 200 U/mL) and insulin glargine (100, 300 U/mL) – a review of evidence and clinical interpretation |
title_full_unstemmed |
Clinical relevance of pharmacokinetic and pharmacodynamic profiles of insulin degludec (100, 200 U/mL) and insulin glargine (100, 300 U/mL) – a review of evidence and clinical interpretation |
title_sort |
Clinical relevance of pharmacokinetic and pharmacodynamic profiles of insulin degludec (100, 200 U/mL) and insulin glargine (100, 300 U/mL) – a review of evidence and clinical interpretation |
author_id_str_mv |
2fd4b7c3f82c6d3bd546eff61ff944e9 |
author_id_fullname_str_mv |
2fd4b7c3f82c6d3bd546eff61ff944e9_***_David Owens |
author |
David Owens |
author2 |
D.R. Owens T. S Bailey C.G. Fanelli J.-F. Yale G.B. Bolli David Owens |
format |
Journal article |
container_title |
Diabetes & Metabolism |
publishDate |
2018 |
institution |
Swansea University |
issn |
12623636 |
doi_str_mv |
10.1016/j.diabet.2018.11.004 |
college_str |
Faculty of Medicine, Health and Life Sciences |
hierarchytype |
|
hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
document_store_str |
1 |
active_str |
0 |
published_date |
2018-12-31T03:57:51Z |
_version_ |
1763752931369156608 |
score |
11.035765 |